Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 9-MTH group results

Jan 30 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2018        Dec 31, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             25.89               22.65            35.80    
                 (+14.3 pct)         (+9.7 pct)       (+10.8 pct) 
  Operating          3.43                1.61             5.20    
                (+113.4 pct)         (-41.0 pct)      (+46.2 pct) 
  Recurring          3.55                1.76             5.40    
                (+101.4 pct)         (-38.6 pct)      (+39.8 pct) 
  Net                2.09                1.07             3.15    
                 (+95.4 pct)         (-31.5 pct)      (+34.9 pct) 
  EPS             17.35 yen           8.88 yen         26.16 yen  
  Ann Div                             4.50 yen         7.00 yen   
  -Q2 div            NIL                 NIL                      
  -Q4 div                             4.50 yen         7.00 yen   
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news